Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
| Image |  |
|---|---|
| Description | scientific article published on 12 April 2017 |
| Author/s |
author: Brian G. Feagan Geert D'Haens Olivier Dewit William Jeffery Sandborn Ursula Seidler Edouard Louis Stefan Schreiber Markus Neurath Marc Ferrante |
| Publication date | April 12, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |